Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMA's RSI Indicator exited the oversold zone, 21 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 59 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for BMA turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 27 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BMA entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.262). P/E Ratio (0.001) is within average values for comparable stocks, (13.480). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.194). Dividend Yield (0.033) settles around the average of (0.036) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.740).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The 50-day moving average for DGS moved below the 200-day moving average on November 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DGS as a result. In 67 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for DGS turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 38 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
DGS moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DGS crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for DGS entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DGS's RSI Indicator exited the oversold zone, 23 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where DGS advanced for three days, in 267 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
DGS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
BMA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | |
SMR RATING 1..100 | 1 | |
PRICE GROWTH RATING 1..100 | 77 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BMA | DGS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 68% | 3 days ago 81% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 76% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 70% |
| Advances ODDS (%) | about 1 month ago 80% | 11 days ago 80% |
| Declines ODDS (%) | 8 days ago 78% | 2 days ago 76% |
| BollingerBands ODDS (%) | 2 days ago 72% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 82% | 2 days ago 69% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMA’s FA Score shows that 3 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMA’s TA Score shows that 4 TA indicator(s) are bullish.
BMA (@Regional Banks) experienced а -5.80% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was -3.81%. For the same industry, the average monthly price growth was -2.38%, and the average quarterly price growth was +4.39%.
BMA is expected to report earnings on Nov 25, 2026.
Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
A.I.dvisor indicates that over the last year, BMA has been closely correlated with GGAL. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMA jumps, then GGAL could also see price increases.
| Ticker / NAME | Correlation To BMA | 1D Price Change % | ||
|---|---|---|---|---|
| BMA | 100% | -4.43% | ||
| GGAL - BMA | 91% Closely correlated | -6.16% | ||
| BBAR - BMA | 91% Closely correlated | -6.35% | ||
| SUPV - BMA | 89% Closely correlated | -10.36% | ||
| BSAC - BMA | 52% Loosely correlated | -0.33% | ||
| AVAL - BMA | 51% Loosely correlated | -1.10% | ||
More | ||||
A.I.dvisor indicates that over the last year, DGS has been loosely correlated with CAAP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DGS jumps, then CAAP could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MYY | 16.45 | 0.31 | +1.92% |
| ProShares Short S&P Mid Cap400 (MYY) | |||
| MARM | 34.50 | -0.09 | -0.26% |
| FT Vest U.S. Equity Max Buffer ETF - March (MARM) | |||
| XSOE | 39.57 | -0.71 | -1.76% |
| WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE) | |||
| LCOW | 25.81 | -0.50 | -1.90% |
| Pacer S&P 500 Quality FCF Aristocrats ETF (LCOW) | |||
| PTMC | 38.23 | -0.80 | -2.06% |
| Pacer Trendpilot US Mid Cap ETF (PTMC) | |||